Global In Vivo Toxicology Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global In Vivo Toxicology Market Research Report 2024
In vivo toxicology is usually carried out in animals as a whole, so that experimental animals in a certain period of time, according to the actual contact mode of human exposure to a certain amount of foreign compounds, and then observe the animal may appear in the form or function changes. Mammals are commonly used in experiments, such as rats, mice, guinea pigs, rabbits, hamsters, dogs and monkeys. The general toxicity of foreign compounds, such as acute toxicity test, subchronic toxicity test and chronic toxicity test, is usually detected.
According to MRAResearch’s new survey, global In Vivo Toxicology market is projected to reach US$ 6164 million in 2033, increasing from US$ 4194.4 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In Vivo Toxicology market research.
Key companies engaged in the In Vivo Toxicology industry include Thermo Fisher Scientific, Danaher, Charles River Laboratories, Labcorp, The Jackson Laboratory, Data Sciences International, Envigo, Eurofins Scientific and Perkinelmer, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of In Vivo Toxicology were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole In Vivo Toxicology market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In Vivo Toxicology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Thermo Fisher Scientific
Danaher
Charles River Laboratories
Labcorp
The Jackson Laboratory
Data Sciences International
Envigo
Eurofins Scientific
Perkinelmer
SRI International
Taconic Biosciences
Wuxi Apptec
Segment by Type
Chronic Toxicity Testing
Sub-Chronic Toxicity Testing
Sub-Acute Toxicity Testing
Acute Toxicity Testing
Immunotoxicity
Systemic Toxicity
Carcinogenicity
Genotoxicity
Developmental and Reproductive Toxicity(DART)
Other Toxicity Endpoints
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The In Vivo Toxicology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global In Vivo Toxicology market is projected to reach US$ 6164 million in 2033, increasing from US$ 4194.4 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In Vivo Toxicology market research.
Key companies engaged in the In Vivo Toxicology industry include Thermo Fisher Scientific, Danaher, Charles River Laboratories, Labcorp, The Jackson Laboratory, Data Sciences International, Envigo, Eurofins Scientific and Perkinelmer, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of In Vivo Toxicology were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole In Vivo Toxicology market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In Vivo Toxicology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Danaher
Charles River Laboratories
Labcorp
The Jackson Laboratory
Data Sciences International
Envigo
Eurofins Scientific
Perkinelmer
SRI International
Taconic Biosciences
Wuxi Apptec
Segment by Type
Chronic Toxicity Testing
Sub-Chronic Toxicity Testing
Sub-Acute Toxicity Testing
Acute Toxicity Testing
Segment by Application
Immunotoxicity
Systemic Toxicity
Carcinogenicity
Genotoxicity
Developmental and Reproductive Toxicity(DART)
Other Toxicity Endpoints
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The In Vivo Toxicology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source